Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hepatitis B
Manufacturing
VBI Vaccines shrinks 'long-term burn' with $33M Brii Bio deal
The company handed over the rights to its hepatitis B vaccine to partner Brii Biosciences, as well as its manufacturing capabilities at its Israel site.
Zoey Becker
Feb 14, 2024 11:12am
UK's NICE signs off on Gilead's hepatitis D drug
May 15, 2023 10:15am
After FDA rejection, Gilead's Hepcludex set for full EU nod
May 5, 2023 10:36am
Gilead's Vemlidy scores pediatric approval for chronic hep B
Nov 2, 2022 11:15am
FDA swats away Gilead's hepatitis D treatment bulevirtide
Oct 28, 2022 9:52am
Gilead settles Descovy patent feuds with 5 drugmakers
Sep 12, 2022 10:05am